Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | CTSB | P07858 | 2/20 | 0.39 |
| ▸ | PPP3CB | P16298 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 4/20 | 0.35 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.35 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | USP8 | P40818 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8349695 | 0.99 | CYP3A4 (0.47) | CYP3A4CTSBPPP3CBELANEABCC1 | |
| SCHEMBL8348948 | 0.98 | CYP3A4 (0.48) | CYP3A4CTSBPPP3CBELANEABCC1 | |
| SCHEMBL8349697 | 0.95 | CYP3A4 (0.48) | CYP3A4CTSBPPP3CBELANEABCC1 | |
| SCHEMBL8348770 | 0.94 | CYP3A4 (0.48) | CYP3A4CTSBPPP3CBELANEABCC1 | |
| SCHEMBL5693284 | 0.90 | CYP3A4 (0.57) | CYP3A4CTSB | |
| SCHEMBL5692578 | 0.90 | CYP3A4 (0.46) | CYP3A4CTSBPPP3CBELANEABCC1 | |
| SCHEMBL5692629 | 0.89 | CYP3A4 (0.46) | CYP3A4CTSBPPP3CBELANEABCC1 | |
| SCHEMBL6308074 | 0.89 | CYP3A4 (0.57) | CYP3A4CTSB | |
| SCHEMBL2345253 | 0.89 | CYP3A4 (0.62) | CYP3A4CTSBPPP3CB | |
| SCHEMBL5692632 | 0.88 | CYP3A4 (0.58) | CYP3A4CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506000-B9 | HETEROCYCLICSULFONAMIDE HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2011-08-31 | — | — | EP | disclosed |
| EP-1506000-B1 | HETEROCYCLICSULFONAMIDE HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2010-09-15 | — | — | EP | disclosed |
| WO-2003099316-A1 | HETEROCYCLICSULFONAMIDE HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-12-04 | — | — | WO | disclosed |